Search

This paper proposes a method for passive detection of autonomous underwater vehicle (AUV) wakes using a cilium-inspired wake sensor (CIWS), which can be used for the detection and tracking of AUVs. First, the characteristics of the CIWS and its working principle for detecting underwater flow fields are introduced. Then, a flow velocity sensor is used to measure the flow velocities of the “TS MINI” AUV’s wake at different positions, and a velocity field model of the “TS MINI” AUV’s wake is established. Finally, the wake field of the “TS MINI” AUV was measured at various positions using the CIWS. By analyzing the data, the characteristic frequency of the AUV’s propeller is identified, which is correlated with the AUV’s rotation speed and the number of blades. Through further analysis, a mapping model is established between the spectral amplitude of the characteristic frequency at different positions and the corresponding wake velocity. By substituting this mapping model into the AUV’s wake velocity field model, the possible position range of the sensor relative to the AUV propeller can be estimated. The research provides a technical foundation for underwater detection and tracking missions based on wake detection.

BackgroundShort stature is one of the most prevalent endocrine disorders in children, and its genetic basis is a complex and actively researched subject. Currently, there is limited genetic research on exome sequencing for short stature, and more large-scale studies are necessary for further exploration.MethodsThe retrospective study entailed investigation of 98 Chinese children with short statures (height SDS ≤ −2.5) of unknown etiologies recruited between 2017 and 2021. Whole-exome sequencing (WES) was performed on these patients to identify the potential genetic etiologies. The clinical data were reviewed retrospectively to assess the pathogenicity of the identified mutations. Additionally, 31 patients consented to and received recombinant human growth hormone (rhGH) therapy for 12 months. The short-term effects of rhGH treatment were evaluated across different etiologies of patients with short statures.ResultsThe WES results were used to identify 31 different variants in 18 genes among 24 (24.5%) patients. Individuals with more severe short statures were more likely to have underlying genetic etiologies. Short stature accompanied by other phenotypes had significantly higher diagnostic yields than simple severe short stature. The rhGH therapy demonstrated efficacy in most children. Nevertheless, the treatment response was suboptimal in a boy diagnosed with 3M syndrome.ConclusionWES is an important approach for confirming genetic disorders in patients with severe short statures of unknown etiologies, suggesting that it could be used as a primary diagnostic strategy. The administration of rhGH may not be suitable for all children with short statures, and the identification of the genetic cause of short stature by WES has significant guidance value for rhGH treatment.